Estudios observacionales
A multicenter, prospective observational RWE study to assess Patient-reported wellbeing using tildrakizumab in a live setting – POSITIVE Study
Promotor: Almirall
Codigo: M-14745-47
Investigador principal: José Carlos Ruiz Carrascosa
En activo
Estudio IMPULSE: “A non-interventional, multicentre study to characterise the clinical characteristics, disease burden, and unmet medical needs of Generalized Pustular Psoriasis (GPP) patients in Spain”. IMPULSE study (IMPacto Psoriasis pUstuLoSa generalizada en España).
Promotor: Boehringer Ingelheim
Código protocolo: 1368-0103
IP local. Ricardo Ruiz Villaverde
Concluido y pendiente de publicación
Ensayos clínicos
EudraCT: LP0160—510
Investigador principal: Jose Carlos Ruiz Carrascosa
Nº centro: ESP1493
Iniciado en 2021. Concluido en 2022 (n=1)
Psoriasis Longitudinal Assessment and Registry (PSOLAR). Registry C0168Z03. A Multicenter, Open Registry of Patients with Psoriasis Who Are Candidates for Systemic Therapy Including Biologics
Código del protocolo: ClinicalTrials.gov Identifier: NCT00508547
Promotor: Janssen Scientific Affairs, LLC
Investigador principal: Jose Carlos Ruiz Carrascosa
Iniciado en 2020 (n=8)